外体:在慢性肺部疾病中有效的巨细胞相关免疫调节剂
Jianxiong Kang1, Peiyan Hua1, Xiaojing Wu2
1Department of Thoracic Surgery at The Second Hospital of Jilin University, Changchun, Jilin, China.
Frontiers in cell and developmental biology
|April 24, 2024
概括
外体,微小的囊泡,在疾病中显著改变肺巨细胞. 它们可以恶化炎症和癌症,但也为新疗法提供了潜在的潜力,以恢复肺部疾病中的免疫平衡.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 肺部医学 肺部医学
背景情况:
- 巨细胞是肺部的关键免疫细胞,对免疫平衡至关重要.
- 在慢性肺病和癌症中,巨细胞表型 (M1/M2) 发生变化,影响疾病的进展.
- 外体细胞介导细胞间通信,并影响巨细胞的两极分化.
研究的目的:
- 研究外体在调节肺炎疾病和肺癌中巨细胞表型中的作用.
- 探索外体在疾病发病和治疗潜力的双重功能.
主要方法:
- 对肺巨细胞中外体介导细胞间信号的分析.
- 在疾病模型中研究外体对M1/M2巨分极的影响.
- 对肺部疾病的基于外体的治疗策略的评估.
主要成果:
- 外体在肺部疾病中促进亲炎性M1巨细胞和亲瘤M2巨细胞.
- 由重塑的巨细胞释放的外体会加剧炎症和癌症的进展.
- 外体体通过调节巨细胞表型,显示出治疗干预的潜力.
结论:
- 外体在炎症和癌症期间的肺巨细胞的病理重编程中发挥着关键作用.
- 基于外体的向疗法有望通过恢复免疫平衡来治疗慢性炎症性肺病和肺癌.
相关概念视频
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K


